• Molecular NameLoracarbef
  • SynonymLoracarbefum [INN-Latin]
  • Weight335.791
  • Drugbank_IDDB00447
  • ACS_NO76470-66-1
  • Show 3D model
  • LogP (experiment)N/A
  • LogP (predicted, AB/LogP v2.0)-0.39
  • pkaN/A
  • LogD (pH=7, predicted)-2.92
  • Solubility (experiment)N/A
  • LogS (predicted, ACD/Labs)(ph=7)-1.48
  • LogSw (predicted, AB/LogsW2.0)12.56
  • Sw (mg/ml) (predicted, ACD/Labs)10.95
  • No.of HBond Donors4
  • No.of HBond Acceptors6
  • No.of Rotatable Bonds5
  • TPSA95.66
  • StatusFDA approved
  • AdministrationN/A
  • PharmacologyAn antibiotic.
  • Absorption_value100.0
  • Absorption (description)N/A
  • Caco_2N/A
  • Bioavailability94.0
  • Protein binding25.0
  • Volume of distribution (VD)N/A
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • MetabollsmThere is no evidence of metabolism in humans.
  • Half life1 h
  • ExcretionN/A
  • Urinary ExcretionN/A
  • CleranceN/A
  • ToxicityAdverse effects include diarrhea, nausea, stomach upset, vomiting, headache, dizziness, rash, bone marrow depression.
  • LD50 (rat)N/A
  • LD50 (mouse)N/A